Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginase Inhibition and Endothelial Function in Obesity
NCT05536934Phase 1Completed
- Sponsor
- Karolinska Institutet
- Start
- Dec 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of n-hydroxy-nor-l-arginine in obesity, sponsored by Karolinska Institutet. Primary endpoint: Endothelium-dependent change in forearm blood flow. Started Dec 2016; status: completed.
02
Drugs
n-hydroxy-nor-l-arginine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05536934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05536934.